Extreme weakness where even basic activities like climbing stairs or lifting light objects feels impossible
That said, some individuals and healthcare providers have reported positive results in specific cases, particularly when microdosing is used to improve tolerability or address off-label needs
Altogether, muscle loss during GLP1RAs therapy is multifactorial, involving reduced protein intake and negative energy balance, hormonal adaptations, impaired mTOR signaling and protein synthesis, increased proteolysis and potential mitochondrial adaptations, and age, frailty, and physical inactivity as modifiers (Fig
[10] Relative contraindications encompass early polycythemia vera, tobacco amblyopia, and concurrent sensitivity to benzyl alcohol used as a preservative
doi: Moiz, A., Filion, K.B., Tsoukas, M.A., Yu, O.HY., Peters, T.M
Some users report reduced cravings within a few weeks, while others notice no change